Coherus Biosciences, Inc. (CHRS) was a big mover last session, as the company saw its shares rise almost 13% on the day. The upside has been driven by the company’s announcement that it will participate in the 2015 Leerink Global Healthcare Conference to be held on Feb 11 in New York City. This led to more shares changing hands than in a normal session. Yesterday’s rally breaks the recent trend for the company, as the stock is now trading above the volatile price range of $16.60 to $23.00 in the past one-month time frame.
Over the last 30 days, this biopharmaceutical company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Coherus Biosciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A better-ranked stock in the same industry is Affymetrix Inc. (AFFX) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment